Lamictal is also known by its drug name, Lamotrigine
Nov 2, 2023 · Mild to moderate depression can generally be treated in an outpatient or
Feb 10, 2012 · 1 Altmetric Explore all metrics Abstract To review the available data behind
Aug 9, 2017 · Conclusions
Apr 12, 2013 · Lamotrigine is an important medication option for the treatment of bipolar
Unipolar depression 4
Data suggest that lamotrigine is a promising drug for treatment-refractory unipolar depression
Depending upon type depression person is facing at a time; the unipolar depression symptoms may vary
Significant improvements in Hamilton Rating Scale for Depression scores and response rates were shown in lamotrigine augmentation groups compared with control groups, of which the pooled result of six Chinese studies showed positive effects of
However, it is also becoming increasingly popular as a treatment option for depression
80 In a review of T3 supplementation for patients with BD-D (n=353), T3 was found to augment and accelerate treatment response to antidepressants and lithium, as well as protect against relapse during the first few years of treatment
4% of the U
Patient 3: Prozac 10 mg daily, Seroquel 25 mg QHS, Lamictal 50 mg daily
Its primary benefit is increasing the time between the relapse of mood episodes, up to double that of placebo (11, 12)
For those 18 years and older, Lamictal is used for maintenance treatment of bipolar disorder to reduce the occurrence of mood episodes
The initial study randomized patients with bipolar depression to receive OFC (6 and 25, 6 and 50, or 12 and 50 mg/day [ n = 86]), olanzapine monotherapy ( n = 370), or placebo ( n = 377) for 8 weeks [ 19 ]
However, results from these studies have been mixed, and efficacy may be limited to certain subpopulations of patients such as those with severe
2013; 2013 (14):334–385
I've been on Wellbutrin 450 mg for years, but it wasn't working so great
being unable to get pleasure from hobbies, relationships, or other previously enjoyed Nov 7, 2014 · Lamotrigine Augmentation Strategy for Patients with Treatment-Resistant Depression - Volume 10 Issue 10